We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
526
DELISTED
Everi Holdings
EVRI
| $1.95M | 0.03% |
212,115
+68,249
| +47% | +$560K |
|
|
HT
527
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.94M | 0.03% |
85,627
+13,200
| +18% | +$296K |
|
528
AT&T
T
$165B
| $1.94M | 0.03% |
76,343
-235,323
| -76% | -$5.76M |
|
|
IMGN
529
DELISTED
Immunogen Inc
IMGN
| $1.92M | 0.03% |
203,207
-22,657
| -10% | -$218K |
|
|
CSGS
530
DELISTED
CSG Systems International
CSGS
| $1.89M | 0.03% |
47,087
-12,930
| -22% | -$511K |
|
531
Westlake Corp
WLK
$9.46B
| $1.89M | 0.03% |
22,680
-10,580
| -32% | -$1.03M |
|
532
Daktronics
DAKT
$941M
| $1.88M | 0.03% |
240,101
+68,924
| +40% | +$566K |
|
533
Four Corners Property Trust
FCPT
$2.86B
| $1.88M | 0.03% |
+73,148
| New | +$1.89M |
|
534
EnerSys
ENS
$6.95B
| $1.87M | 0.03% |
21,450
+1,400
| +7% | +$112K |
|
|
X
535
DELISTED
US Steel
X
| $1.85M | 0.03% |
+60,733
| New | +$1.96M |
|
536
Lexicon Pharmaceuticals
LXRX
$1.02B
| $1.85M | 0.03% |
173,330
+2,223
| +1% | +$25.5K |
|
537
WesBanco
WSBC
$3.95B
| $1.84M | 0.03% |
41,244
+7,990
| +24% | +$382K |
|
538
Ryman Hospitality Properties
RHP
$8.4B
| $1.84M | 0.03% |
21,312
-14,358
| -40% | -$1.23M |
|
539
Standard BioTools
LAB
$326M
| $1.83M | 0.03% |
243,947
-11,345
| -4% | -$80.7K |
|
540
Nike
NKE
$61.9B
| $1.83M | 0.03% |
+21,560
| New | +$1.73M |
|
|
FBM
541
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $1.82M | 0.03% |
145,853
+27,625
| +23% | +$387K |
|
|
OPB
542
DELISTED
Opus Bank Common Stock
OPB
| $1.81M | 0.03% |
65,917
+21,125
| +47% | +$604K |
|
543
Dick's Sporting Goods
DKS
$18.4B
| $1.79M | 0.03% |
50,330
-288,100
| -85% | -$10.3M |
|
|
KDNY
544
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.76M | 0.03% |
47,860
+8,424
| +21% | +$270K |
|
|
OXFD
545
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.75M | 0.02% |
107,505
-10,649
| -9% | -$152K |
|
546
V2X
VVX
$2.62B
| $1.73M | 0.02% |
55,522
+6,245
| +13% | +$201K |
|
547
HubSpot
HUBS
$10.5B
| $1.72M | 0.02% |
+11,362
| New | +$1.56M |
|
548
QCR Holdings
QCRH
$1.65B
| $1.72M | 0.02% |
41,973
+10,615
| +34% | +$473K |
|
549
Allient
ALNT
$1.47B
| $1.7M | 0.02% |
46,955
+8,324
| +22% | +$270K |
|
550
Archrock
AROC
$6.33B
| $1.69M | 0.02% |
138,813
-143,309
| -51% | -$1.81M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.